No detection of parvovirus B19 or herpesvirus DNA in giant cell arteritis

Journal of Clinical Virology

Volumn 31, Issue 1, 2004, Pages 11-15

  Rodriguez Pla, Alicia ^a,b   Bosch Gil, Josep A ^b   Echevarria Mayo, Juan E ^c   Rossello Urgell, José ^b   Solans Laque, Roser ^b   Huguet Redecilla, Pere ^b   Stone, John H ^d   Vilardell Tarres, Miquel ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

EBV; Epstein Barr virus; GCA; giant cell arteritis; Giant cell arteritis; HCMV; herpes simplex virus; HHV 6; HSV; human cytomegalovirus; human herpesvirus 6; IDO; indoleamine 2,3 dioxygenase; PCR; polymerase chain reaction; varicella zoster virus; VZV

Indexed keywords

BETA GLOBIN; INDOLEAMINE 2,3 DIOXYGENASE; PARAFFIN; VIRUS DNA;

AGED; ARTICLE; BLOOD VESSEL BIOPSY; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; GENE AMPLIFICATION; GIANT CELL ARTERITIS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 6; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PARVOVIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TEMPORAL ARTERY; VARICELLA ZOSTER VIRUS; VIRUS DETECTION; VIRUS DIAGNOSIS; WORLD HEALTH ORGANIZATION;

AGED; BIOPSY; DNA, VIRAL; FEMALE; GLOBINS; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; MALE; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; TEMPORAL ARTERIES; TEMPORAL ARTERITIS; TRYPTOPHAN OXYGENASE;

EID: 3543066443     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2004.05.003     Document Type: Article

References (34)

1. Abel G., Zhang Q.X., Agnello V. Hepatitis C virus infection in type II mixed cryoglobulinemia. Arthritis Rheum. 36:1993;1341-1349
2. Casas I., Tenorio A., Echevarria J.M., Klapper P.E., Cleator G.M. Detection of enteroviral RNA and specific DNA of herpesviruses by multiplex genome amplification. J. Virol. Methods. 66:1997;39-50
3. Dal Canto A.J., Virgin H.W. IV, Speck S.H. Ongoing viral replication is required for gammaherpesvirus 68-induced vascular damage. J. Virol. 74:2000;11304-11310
4. Dal Canto A.J., Swanson P.E., O'Guin A.K., Speck S.H., Virgin H.W. INF-gamma action in the media of the great elastic arteries, a novel immunoprivileged site. J. Clin. Invest. 107:2001;R15-R22
5. Duffy J., Lidsky M.D., Sharp J.T., et al. Polyarthritis, polyarteritis and hepatitis B. Medicine (Baltimore). 55:1976;19-37
6. Fest T., Mougin C., Dupond J.L. Giant cell arteritis. Ann. Intern. Med. 124:1996;927-928
7. Fukumoto S., Kinjo M., Hokamura K., Tanaka K. Subarachnoid hemorrhage and granulomatous angiitis of the basilar artery: demonstration of the varicella-zoster-virus in the basilar artery lesions. Stroke. 17:1986;1024-1028
8. Gabriel S.E., Espy M., Erdman D.D., Bjornsson J., Smith T.F., Hunder G.G. The role of parvovirus B19 in the pathogenesis of giant cell arteritis: a preliminary evaluation. Arthritis Rheum. 42:1999;1255-1258
9. Helweg-Larsen J., Tarp B., Obel N., Baslund B. No evidence of parvovirus B19, Chlamydia pneumoniae or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritis. Rheumatol. Oxford. 41:2002;445-449
10. Kennedy P.G., Grinfeld E., Esiri M.M. Absence of detection of varicella-zoster virus DNA in temporal artery biopsies obtained from patients with giant cell arteritis. J. Neurol. Sci. 215:2003;27-29
11. Krueger G.R., Papadakis T., Schaefer H.J. Persistent active Epstein-Barr virus infection and atypical lymphoproliferation. Report of two cases. Am. J. Surg. Pathol. 11:1987;972-981
12. Lie J.T. Illustrated histopathologic classification criteria for selected vasculitis syndromes. Arthritis Rheum. 33:1990;1074-1087. American College of Rheumatology Subcommittee on Classification of Vasculitis
13. Lunardi C., Tiso M., Borgato L., et al. Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties. Eur. J. Immunol. 28:1998;936-948
14. Magro C.M., Crowson A.N., Dawood M., Nuovo G.J. Parvoviral infection of endothelial cells and its possible role in vasculitis and autoimmune diseases. J. Rheumatol. 29:2002;1227-1235
15. Mehler M.F., Rabinowich L. The clinical neuro-opthalmologic spectrum of temporal arteritis. Am. J. Med. 85:1988;839-844
16. Miller C.L., Yolken R.H. Methods to optimize the generation of cDNA from postmortem human brain tissue. Brain Res. Brain Res. Protoc. 10:2003;156-167
17. Mitchell B.M., Font R.L. Detection of varicella zoster virus DNA in some patients with giant cell arteritis. Invest. Ophthalmol. Vis. Sci. 42:2001;2572-2577
18. Mitchell L.A., Leong R., Rosenke K.A. Lymphocyte recognition of human parvovirus B19 non-structural (NS1) protein: associations with occurrence of acute and chronic arthropathy? J. Med. Microbiol. 50:2001;627-635
19. Moffatt S., Tanaka N., Tada K., et al. A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression. J. Virol. 70:1996;8485-8491
20. Moffatt S., Yaegashi N., Tada K., Tanaka N., Sugamura K. Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells. J. Virol. 72:1998;3018-3028
21. Mosquera M.M., de Ory F., Moreno M., Echevarria J.E. Simultaneous detection of measles virus, rubella virus, and parvovirus B19 by using multiplex PCR. J. Clin. Microbiol. 40:2002;111-116
22. Saldanha J., Lelie N., Yu M.W., Heath A. Establishment of the first World Health Organization International Standard for human parvovirus B19 DNA nucleic acid amplification techniques. Vox Sang. 82:2002;24-31
23. Salvarani C., Gabriel S.E., O'Fallon W.M., Hunder G.G. The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann. Intern. Med. 123:1995;192-194
24. Salvarani C., Farnetti E., Casali B., et al. Detection of parvovirus B19 DNa by polymerase Caín reaction in giant cell arteritis: a case-control study. Arthritis Rheum. 46:2002;3099-3101
25. Sato Y., Sugie R., Tschiya B., Kameya T., Natori M., Mukai K. Comparison of the DNA extraction methods for polymerase chain reaction amplification from formalin-fixed and paraffin-embedded tissues. Diagn. Mol. Pathol. 10:2001;265-271
26. Takatsuka H., Wakae T., Mori A., et al. Endothelial damage caused by cytomegalovirus and human herpesvirus-6. Bone Marrow Transplant. 31:2003;475-479
27. Teitelbaum C.S., Streeten B.W., Dawson C.R. Histopathology of herpes simplex virus keratouveitis. Curr. Eye Res. 6:1987;189-194
28. Tenorio A., Echevarria J.E., Casas I., Echevarria J.M., Tabares E. Detection and typing of human herpesviruses by mulitplex polymerase Caín reaction. J. Virol. Methods. 44:1993;261-269
29. von Poblotzki A., Gerdes C., Reischl U., Wolf H., Modrow S. Lymphoproliferative responses alter infection with human parvovirus B19. J. Virol. 70:1998;7327-7330
30. Watts R.A., Scott D.G. Epidemiology of the vasculitides. Curr. Opin. Rheumatol. 15:2003;11-16
31. Weck K.E., Dal Canto A.J., Gould J.D., et al. Murine gammaherpesvirus 68 causes large vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus induced vascular disease. Nat. Med. 3:1997;1346-1353
32. Weyand C.M., Goronzy J.J. Giant-cell arteritis and polymyalgia rheumatica. Ann. Intern. Med. 139:2003;505-515
33. Wilhelmus K.R., Font R.L., Lehmann R.P., Cernoch P.L. Cytomegalovirus keratitis in acquired immunodeficiency syndrome. Arch. Ophthalmol. 114:1996;869-872
34. Young N.S., Brown K.E. Parvovirus B19. N. Engl. J. Med. 350:2004;586-597